Fingerprint
Dive into the research topics of 'Real-world effectiveness for 12 weeks of ledipasvir–sofosbuvir for genotype 1 hepatitis C: the Trio Health study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Real-world effectiveness for 12 weeks of ledipasvir–sofosbuvir for genotype 1 hepatitis C: the Trio Health study
E. B. Tapper, B. R. Bacon, M. P. Curry, D. T. Dieterich, S. L. Flamm, L. E. Guest, K. V. Kowdley, Y. Lee, N. C. Tsai, Z. M. Younossi, N. H. Afdhal
Research output: Contribution to journal › Article › peer-review
65
Scopus
citations